521
The combination of cyclobenzaprine and fluoxetine resulted in significant QT prolongation in our patient that progressed to torsade de pointes after preoperative droperidol administration.
 our patient: Subject; significant QT prolongation: Effect; progressed to torsade de pointes: Effect; The combination of cyclobenzaprine and fluoxetine: Treatment; preoperative droperidol administration: Treatment; cyclobenzaprine: Treatment.Drug; fluoxetine: Treatment.Drug; droperidol: Treatment.Drug; preoperative: Treatment.Time_elapsed; cyclobenzaprine: Combination.Drug; fluoxetine: Combination.Drug; droperidol: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 our patient: Subject; significant QT prolongation: Effect; progressed to torsade de pointes: Effect; The combination of cyclobenzaprine and fluoxetine: Treatment; preoperative droperidol administration: Treatment; cyclobenzaprine: Treatment.Drug; fluoxetine: Treatment.Drug; droperidol: Treatment.Drug; preoperative: Treatment.Time_elapsed; cyclobenzaprine: Combination.Drug; fluoxetine: Combination.Drug; droperidol: Combination.Drug